Thiobutabarbital

drugbox
IUPAC_name = 5-butan-2-yl-5-ethyl-2-sulfanylidene-1,3-diazinane-4,6-dione
synonyms = Thiobutabarbital, Inactin, Brevinarcon, 5-sec-Butyl-5-ethyl-2-thiobarbituric acid

---

width = 100
CAS_number = 2095-57-0
ATC_prefix =
ATC_suffix =
PubChem = 3032373
DrugBank =
C = 10 | H = 16 | N = 2 | O = 2 | S = 1
molecular_weight = 228.312 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

Thiobutabarbital (Inactin, Brevinarcon) is a short-acting barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant and hypnotic effects, and is still used in veterinary medicine for induction in surgical anaesthesia [ Rieg T, Richter K, Osswald H, Vallon V. Kidney function in mice: thiobutabarbital versus alpha-chloralose anesthesia. Naunyn Schmiedebergs Archives of Pharmacology. 2004 Oct;370(4):320-3. ]

References